Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
BA-SCAD: Beta-Blockers and Antiplatelets in SCAD
NCT04850417Phase 4Not yet recruiting
- Sponsor
- Sociedad Española de Cardiología
- Start
- Apr 2021
- Primary completion
- Dec 2024
- Modality
- Orthosteric Ligands
01
Overview
A Phase 4 trial of carvedilol, aspirin, clopidogrel in spontaneous coronary artery dissection (SCAD), sponsored by Sociedad Española de Cardiología. Planned start Apr 2021; status: not yet recruiting.
02
Drugs
carvedilolaspirinclopidogrel
03
Conditions
spontaneous coronary artery dissection (SCAD)
Beyond the preview
Go deeper on NCT04850417.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04850417.